Fulcrum Equity Management’s Abbott ABT Stock Holding History

Fulcrum Equity Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,099	Closed	-$239K	–	111
2024 Q3	$239K	Buy	+2,099	New	+$230K	0.2%	125

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Fulcrum Equity Management's ABT Position: Q4 2024 in Review

Fulcrum Equity Management sold out of Abbott (ABT) in Q4 2024, closing a stake of 2,099 shares — an estimated $239K sold.

Fulcrum Equity Management first reported a position in ABT in Q3 2024 and held it in 1 quarter. The position peaked at $239K in Q3 2024. 3,066 funds tracked by Wall St. Rank hold ABT as of Q4 2024.

Fulcrum Equity Management reported no remaining Abbott position as of Q4 2024 after selling out during the quarter.
Fulcrum Equity Management sold 2,099 Abbott shares in Q4 2024, an estimated $239K.
Fulcrum Equity Management first reported a position in Abbott in Q3 2024 and held it in 1 quarter.
Fulcrum Equity Management's Abbott position peaked at $239K in Q3 2024.
3,066 funds tracked by Wall St. Rank held Abbott as of Q4 2024.

Based on Fulcrum Equity Management's 13F filing for Q4 2024, filed 24 Mar 2025.